Pluri
PublicPluri is now publicly traded
The data on this page reflects Pluri's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Feb 4, 2025
Total Funding Raised
$248.68M
Company Overview
Pluri Inc. is a biotechnology company that develops cell-based products for a variety of industries, including regenerative medicine, food technology, and agriculture technology.
AI Layer
Non-AI
Keywords
Pluri Comparables
Compare Pluri with similar companies based on industry and business-model similarity.
No public comparables are available for Pluri. Request access to learn about comparables coverage.
Request accessPluri Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Feb 4, 2025 | ||||
| Private Placement | Jan 23, 2025 | ||||
| Grant | Nov 10, 2021 | ||||
| Debt | May 25, 2021 | ||||
| Follow-on Offering | Feb 2, 2021 | ||||
Follow-on Offering | May 5, 2020 |
Key People
Founding team and executive leadership
Pluri Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MJR PharmJet | Grant |
| European Commission (Horizon Europe) | Grant |
| H.C. Wainwright & Co. | Private Placement, Follow-on Offering |
| Israel Innovation Authority | Grant |
| Innovative Medical Management Co. Ltd. | Private Placement |
| European Investment Bank Group | Debt |
| Vall d'Hebron Research Institute | Grant |
Pluri Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access